What top creators are saying about Sonnet Biotherapeutics Holdings, Inc.(SONN)

A higher-risk, higher-reward play on the Hyperliquid thesis. If its merger is successful, it is expected to become the primary institutional vehicle for HYPE exposure, potentially giving institutions the 'green light' to invest.

A speculative play that is merging to become Hyperliquid Strategies (HSI). The speaker advises waiting for the merger and a subsequent price drop before considering an investment, stating 'This could go horribly wrong.'

Making an 'unusual move' and a 'novel and high-risk' pivot from biotech to becoming a corporate holder of the HYPE token, representing a highly speculative and uncertain corporate strategy.

This public company was formed as a vehicle to hold HYPE tokens, but it is part of a model that hosts warned could be a sign of a bubble and advised caution.

Explicitly warned against as a 'biotech zombie' with terrible financials, using the HYPE narrative in a desperate attempt to pump its stock. The host advises to 'not touch these puppies.'

The stock's tripling after announcing a merger to acquire Hyperliquid is used as an example of the 'speculative nature' and 'market froth' in the crypto-related equity sector.

Announced an $888 million business combination to become the largest treasury for the crypto asset Hype, expecting to hold $580 million worth of it, representing the expanding corporate treasury trend.